PERRIGO COMPANY PLC - PRGO STOCK NEWS

Perrigo Company plc (NYSE; TASE: PRGO) has announced the release of its fourth quarter and full year 2020 financial results on March 1, 2021, at 8:00 a.m. (EST). A conference call will follow, accessible via webcast on the Perrigo website or by phone. The company is a leading provider of self-care products and over-the-counter health solutions, holding a significant market share in the U.S. and Europe. Forward-looking statements highlight potential risks, including impacts from the COVID-19 pandemic, competition, and regulatory challenges.

Perrigo Company plc (NYSE: PRGO) has formed a partnership with Michigan State University (MSU) aimed at enhancing consumer self-care through innovative products and research. This collaboration merges MSU's clinical expertise with Perrigo's manufacturing capabilities and retail networks, focusing on the development of customized self-care solutions. Executives from both organizations emphasized the importance of accessibility and quality in self-care products, noting their commitment to improving health outcomes for consumers globally.

Perrigo Company plc (NYSE: PRGO) announced that Rich Sorota, EVP and President of Consumer Self-Care Americas, will present at the ICR Conference on January 11, 2021, at 11:30 AM EST. Additionally, CEO Murray S. Kessler and CFO Ray Silcock will present at the J.P. Morgan Global Healthcare Conference on January 13, 2021, at 3:40 PM EST. Both presentations can be accessed via webcasts. Perrigo is a leading provider of self-care products and is the largest store brand OTC player in the U.S., with over 9,000 SKUs. More details can be found on their investor relations website.

Perrigo Company plc (NYSE; TASE: PRGO) will present at the Morgan Stanley Global Consumer & Retail Conference on December 1, 2020, at 1:00 PM EST. CEO Murray S. Kessler and CFO Ray Silcock will lead the presentation, which will be accessible via webcast. Perrigo is a leading provider of affordable self-care products, ranking as the largest store brand OTC player in the U.S. and a top 5 OTC company in Europe. The company focuses on enhancing consumer wellness and offers over 9,000 SKUs under various brand labels.

Perrigo Company reported Q3 2020 net sales of $1.2 billion, up 1.3% year-over-year, driven by robust growth in its Consumer Self-Care segment. The company achieved record net sales of $664 million in Consumer Self-Care Americas, a 7.3% increase, while organic net sales grew 1.6%. Despite challenges, including a $202 million goodwill impairment and a diluted net loss per share of $1.13, Perrigo reaffirmed its fiscal outlook for 2020, projecting net sales growth of 6-7% and adjusted EPS of $3.95-$4.15. The company remains optimistic about its self-care evolution and e-commerce strategy.

Perrigo Company plc (NYSE: PRGO) announced a ruling from the Irish High Court stating that the issuance of a Notice of Amended Assessment by Irish Revenue in November 2018 did not violate the company's legitimate expectations. No payment is required due to this ruling. However, the High Court did not quash the assessment, allowing Perrigo to either appeal the decision or challenge the assessment's merits before the Irish Tax Appeals Commission. The company maintains that the assessment is without merit and remains committed to defending its position.

Perrigo Company plc (NYSE: PRGO) has acquired three OTC skincare brands—Emolium®, Iwostin®, and Loxon®—from Sanofi, marking a significant step in its transformation into a consumer-focused self-care company. This acquisition aims to tap into growth opportunities in Eastern Europe and is expected to enhance Perrigo's existing product portfolio. Executive VP Svend Andersen emphasized the strategic importance of leveraging high-quality skincare and expanding into new markets. The company is a major player in the OTC sector, with over 9,000 SKUs under store brand labels in the U.S. and a strong presence in Europe.

Steripod, a brand under Perrigo Company plc (NYSE: PRGO), emphasizes the importance of hygiene during the holiday season amidst COVID-19 concerns. The Steripod Toothbrush Protector offers protection against airborne contaminants, ensuring safe travel and hygiene practices. This product, infused with natural Thymol vapors, keeps toothbrushes clean for up to three months. Travelers are encouraged to adopt additional safety measures such as masks and sanitizers to prevent illness. For more information, visit getsteripod.com.

Perrigo Company plc (NYSE: PRGO) announced a scheduling update for its third quarter financial results call to November 4, 2020, at 4:30 p.m. (EST), following a notice from the Irish High Court regarding a pending judicial review of a €1.6 billion assessment by Irish Revenue. The company asserts the assessment is without merit and intends to challenge it. The outcomes of the court's decision may influence the company's financial implications, and no payment is required until all determinations are resolved.